Two truncating variants in FANCC and breast cancer risk.
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Two truncating variants in FANCC and breast cancer risk.

Dörk, Thilo;Peterlongo, Paolo;Mannermaa, Arto;Bolla, Manjeet K;Wang, Qin;Dennis, Joe;Ahearn, Thomas;Andrulis, Irene L;Anton-Culver, Hoda;Arndt, Volker;Aronson, Kristan J;Augustinsson, Annelie;Freeman, Laura E Beane;Beckmann, Matthias W;Beeghly-Fadiel, Alicia;Behrens, Sabine;Bermisheva, Marina;Blomqvist, Carl;Bogdanova, Natalia V;Bojesen, Stig E;Brauch, Hiltrud;Brenner, Hermann;Burwinkel, Barbara;Canzian, Federico;Chan, Tsun L;Chang-Claude, Jenny;Chanock, Stephen J;Choi, Ji-Yeob;Christiansen, Hans;Clarke, Christine L;Couch, Fergus J;Czene, Kamila;Daly, Mary B;Dos-Santos-Silva, Isabel;Dwek, Miriam;Eccles, Diana M;Ekici, Arif B;Eriksson, Mikael;Evans, D Gareth;Fasching, Peter A;Figueroa, Jonine;Flyger, Henrik;Fritschi, Lin;Gabrielson, Marike;Gago-Dominguez, Manuela;Gao, Chi;Gapstur, Susan M;García-Closas, Montserrat;García-Sáenz, José A;Gaudet, Mia M;Giles, Graham G;Goldberg, Mark S;Goldgar, David E;Guénel, Pascal;Haeberle, Lothar;Haiman, Christopher A;Håkansson, Niclas;Hall, Per;Hamann, Ute;Hartman, Mikael;Hauke, Jan;Hein, Alexander;Hillemanns, Peter;Hogervorst, Frans B L;Hooning, Maartje J;Hopper, John L;Howell, Tony;Huo, Dezheng;Ito, Hidemi;Iwasaki, Motoki;Jakubowska, Anna;Janni, Wolfgang;John, Esther M;Jung, Audrey;Kaaks, Rudolf;Kang, Daehee;Kapoor, Pooja Middha;Khusnutdinova, Elza;Kim, Sung-Won;Kitahara, Cari M;Koutros, Stella;Kraft, Peter;Kristensen, Vessela N;Kwong, Ava;Lambrechts, Diether;Marchand, Loic Le;Li, Jingmei;Lindström, Sara;Linet, Martha;Lo, Wing-Yee;Long, Jirong;Lophatananon, Artitaya;Lubiński, Jan;Manoochehri, Mehdi;Manoukian, Siranoush;Margolin, Sara;Martinez, Elena;Matsuo, Keitaro;Mavroudis, Dimitris;Meindl, Alfons;Menon, Usha;Milne, Roger L;Mohd Taib, Nur Aishah;Muir, Kenneth;Mulligan, Anna Marie;Neuhausen, Susan L;Nevanlinna, Heli;Neven, Patrick;Newman, William G;Offit, Kenneth;Olopade, Olufunmilayo I;Olshan, Andrew F;Olson, Janet E;Olsson, Håkan;Park, Sue K;Park-Simon, Tjoung-Won;Peto, Julian;Plaseska-Karanfilska, Dijana;Pohl-Rescigno, Esther;Presneau, Nadege;Rack, Brigitte;Radice, Paolo;Rashid, Muhammad U;Rennert, Gad;Rennert, Hedy S;Romero, Atocha;Ruebner, Matthias;Saloustros, Emmanouil;Schmidt, Marjanka K;Schmutzler, Rita K;Schneider, Michael O;Schoemaker, Minouk J;Scott, Christopher;Shen, Chen-Yang;Shu, Xiao-Ou;Simard, Jacques;Slager, Susan;Smichkoska, Snezhana;Southey, Melissa C;Spinelli, John J;Stone, Jennifer;Surowy, Harald;Swerdlow, Anthony J;Tamimi, Rulla M;Tapper, William J;Teo, Soo H;Terry, Mary Beth;Toland, Amanda E;Tollenaar, Rob A E M;Torres, Diana;Torres-Mejía, Gabriela;Troester, Melissa A;Truong, Thérèse;Tsugane, Shoichiro;Untch, Michael;Vachon, Celine M;Ouweland, Ans M W van den;Veen, Elke M van;Vijai, Joseph;Wendt, Camilla;Wolk, Alicja;Yu, Jyh-Cherng;Zheng, Wei;Ziogas, Argyrios;Ziv, Elad;, ;, ;Dunning, Alison M;Pharoah, Paul D P;Schindler, Detlev;Devilee, Peter;Easton, Douglas F;
Scientific reports 2019 Vol. 9 pp. 12524
247
dork2019twoscientific

Abstract

Fanconi anemia (FA) is a genetically heterogeneous disorder with 22 disease-causing genes reported to date. In some FA genes, monoallelic mutations have been found to be associated with breast cancer risk, while the risk associations of others remain unknown. The gene for FA type C, FANCC, has been proposed as a breast cancer susceptibility gene based on epidemiological and sequencing studies. We used the Oncoarray project to genotype two truncating FANCC variants (p.R185X and p.R548X) in 64,760 breast cancer cases and 49,793 controls of European descent. FANCC mutations were observed in 25 cases (14 with p.R185X, 11 with p.R548X) and 26 controls (18 with p.R185X, 8 with p.R548X). There was no evidence of an association with the risk of breast cancer, neither overall (odds ratio 0.77, 95%CI 0.44-1.33, p = 0.4) nor by histology, hormone receptor status, age or family history. We conclude that the breast cancer risk association of these two FANCC variants, if any, is much smaller than for BRCA1, BRCA2 or PALB2 mutations. If this applies to all truncating variants in FANCC it would suggest there are differences between FA genes in their roles on breast cancer risk and demonstrates the merit of large consortia for clarifying risk associations of rare variants.

Keywords

molecular docking enzyme inhibition carbonic anhydrase computational studies

Access

DOI:
10.1038/s41598-019-48804-y

Citation

ID: 43612
Ref Key: dork2019twoscientific
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
43612
Unique Identifier:
10.1038/s41598-019-48804-y
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store